RxDoctor Payments Data

Louis Cady

Psychiatry · Newburgh, INNPI 1053454413

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $91,657 of the $134,719 with a category attached, or 68.0%. 41 manufacturers reported payments, led by Corium, LLC at 41.8% of the total. Reporting peaked in 2022 at $34,283 and has fallen 85.8% since, to $4,856 in 2025. Among psychiatry clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$134,719in general payments, 2019–2025

Across 617 payments — averaging $218.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corium, LLC$56K
  • Tris Pharma Inc$26K
  • Ironshore Pharmaceuticals Inc.$24K
  • Takeda Pharmaceuticals U.S.A., Inc.$16K
  • Supernus Pharmaceuticals, Inc.$5K
  • Vanda Pharmaceuticals Inc.$1K
  • plus $6K from 35 others

What the payments were for

  • Consulting fees$11,4008%
  • Speaking & faculty fees$91,65768%
  • Travel & lodging$19,54015%
  • Food & beverage$11,7669%
  • Education$3550%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$134,719 in reported general payments places this provider in the 95th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
WakixPitolisant Hcl13$100,205
TrintellixVortioxetine Hydrobromide55$35,970
LybalviOlanzapine/Samidorphan Malate13$20,158
VraylarCariprazine Hcl13$19,768
Emgality PenGalcanezumab-Gnlm12$19,176
VyvanseLisdexamfetamine Dimesylate19$10,949
BelsomraSuvorexant16$6,632
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate13$4,178
Vilazodone Hcl28$3,853
Liothyronine Sodium53$2,188
ProgesteroneProgesterone, Micronized48$1,601
Bupropion XlBupropion Hcl66$1,470
Armour ThyroidThyroid,pork13$933
Omega-3 Acid Ethyl Esters13$672
Duloxetine Hcl23$595

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Harmony Biosciences LLCWakix$374$100,20513 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$16,346$46,91974 claims
AbbVieVraylar, Armour Thyroid$633$20,70126 claims
Alkermes, Inc.Lybalvi$542$20,15813 claims
MerckBelsomra$72$6,63216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 514 psychiatry providers in Indiana.

Other psychiatry in Newburgh

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →